Anterior Chamber-Associated Immune Deviation

Veterinary Clinics of North America - Small Animal Practice

Volumn 38, Issue 2, 2008, Pages 309-321

  Biros, Daniel ^a  

^a ANGELL ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL DISEASE; ANTERIOR EYE CHAMBER ASSOCIATED IMMUNE DEVIATION; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; EYE DISEASE; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; SKIN GRAFT; SPLEEN FUNCTION; T LYMPHOCYTE ACTIVATION; THYMUS FUNCTION; VISUAL SYSTEM FUNCTION; ANIMAL; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTATION; DELAYED HYPERSENSITIVITY; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; ANTERIOR CHAMBER; ANTIGEN PRESENTATION; EYE DISEASES; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; T-LYMPHOCYTES;

EID: 44249099290     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2007.12.006     Document Type: Review

References (104)

1. Kezuka T., Sakai J., Usui N., et al. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch Ophthalmol 119 (2001) 1044-1049
2. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3 (2003) 879-889
3. van Dooremaal J. Die Entwicklung der in fremden Grund versetzten lebenden Gewebe. Albrecht von Graefes Arch Ophthalmol 19 (1873) 358-373
4. Medawar P. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29 (1948) 58-69
5. Kaplan H.J., Streilein J.W., and Stevens T.R. Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells. J Immunol 115 (1975) 805-810
6. Benson J.L., and Niederkorn J.Y. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens. Immunology 77 (1992) 189-195
7. Streilein J.W., Okamoto S., Hara Y., et al. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen. Invest Ophthalmol Vis Sci 38 (1997) 2245-2254
8. Wilbanks G.A., Mammolenti M., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 146 (1991) 3018-3024
9. Lin H.H., Faunce D.E., Stacey M., et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201 (2005) 1615-1625
10. Ferguson T.A., and Herndon J.M. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest Ophthalmol Vis Sci 35 (1994) 3085-3093
11. Ferguson T.A., and Kaplan H.J. The immune response and the eye. I. The effects of monoclonal antibodies to T suppressor factors in anterior chamber-associated immune deviation (ACAID). J Immunol 139 (1987) 346-351
12. Waldrep J.C., and Kaplan H.J. Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID). II. Suppressor T-cell networks. Invest Ophthalmol Vis Sci 24 (1983) 1339-1345
13. Skelsey M.E., Mayhew E., and Niederkorn J.Y. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 110 (2003) 18-29
14. Stein-Streilein J., and Streilein J.W. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol 21 (2002) 123-152
15. Streilein J.W., Masli S., Takeuchi M., et al. The eye's view of antigen presentation. Hum Immunol 63 (2002) 435-443
16. Niederkorn J.Y. Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 22 (2002) 13-46
17. D'Orazio T.J., and Niederkorn J.Y. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160 (1998) 2089-2098
18. Kosiewicz M.M., Alard P., and Streilein J.W. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production. J Immunol 161 (1998) 5382-5390
19. Li X.Y., D'Orazio L.T., and Niederkorn J.Y. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 89 (1996) 34-40
20. Katagiri K., Zhang-Hoover J., Mo J.S., et al. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J Immunol 169 (2002) 84-89
21. Kosiewicz M.M., and Streilein J.W. Is deviant immunity induced by intraocular injection of antigen dependent on Th2 cells?. Invest Ophthalmol Vis Sci 37 (1996) S1136
22. Nakamura T., Terajewicz A., and Stein-Streilein J. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol 175 (2005) 2643-2646
23. Streilein J.W., and Wilbanks G.A. Evidence that anterior chamber and intravenous antigen injections have distinctly different systemic immune consequences. Ocular Immunol Today (1990) 255-258
24. D'Orazio T.J., and Niederkorn J.Y. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 95 (1998) 47-55
25. Skelsey M.E., Mayhew E., and Niederkorn J.Y. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 44 (2003) 5242-5251
26. Vella A.T., Scherer M.T., Schultz L., et al. B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci U S A 93 (1996) 951-955
27. Wilbanks G.A., and Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71 (1990) 383-389
28. Faunce D.E., Sonoda K.H., and Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 166 (2001) 313-321
29. Hara Y., Okamoto S., Rouse B., et al. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J Immunol 151 (1993) 5162-5171
30. Sonoda K.H., Faunce D.E., Taniguchi M., et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 166 (2001) 42-50
31. Wilbanks G.A., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 146 (1991) 2610-2617
32. Whittum J.A., Niederkorn J.Y., McCulley J.P., et al. Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res 2 (1982) 691-697
33. Egan R.M., Yorkey C., Black R., et al. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 157 (1996) 2262-2271
34. Gordon S., Lawson L., Rabinowitz S., et al. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol 181 (1992) 1-37
35. Austyn J.M., and Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11 (1981) 805-815
36. McKnight A.J., and Gordon S. The EGF-TM7 family: unusual structures at the leukocyte surface. J Leukoc Biol 63 (1998) 271-280
37. McKnight A.J., and Gordon S. EGF-TM7: a novel subfamily of seven-transmembrane-region leukocyte cell-surface molecules. Immunol Today 17 (1996) 283-287
38. Sohn J.H., Bora P.S., Suk H.J., et al. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 9 (2003) 206-212
39. Sherman S.H., Green K., and Laties A.M. The fate of anterior chamber fluorescein in the monkey eye. 1. The anterior chamber outflow pathways. Exp Eye Res 27 (1978) 159-173
40. Sonoda K.H., and Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 32 (2002) 848-857
41. Taylor A.W. Immunoregulation of the ocular effector responses by soluble factors in aqueous humor. Reg Immunol 6 (1994) 52-57
42. Griffith T.S., Yu X., Herndon J.M., et al. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5 (1996) 7-16
43. Kawashima H., Yamagami S., Tsuru T., et al. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur J Immunol 27 (1997) 2490-2494
44. Elzey B.D., Griffith T.S., Herndon J.M., et al. Regulation of Fas ligand-induced apoptosis by TNF. J Immunol 167 (2001) 3049-3056
45. Niederkorn J.Y., Mayhew E., Mellon J., et al. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival. Invest Ophthalmol Vis Sci 45 (2004) 2674-2681
46. Wang Y., Goldschneider I., Foss D., et al. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 158 (1997) 2150-2155
47. Wang Y., Goldschneider I., O'Rourke J., et al. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol 69 (2001) 741-746
48. Goldschneider I., and Cone R.E. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends Immunol 24 (2003) 77-81
49. Sonoda K.H., Exley M., Snapper S., et al. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 190 (1999) 1215-1226
50. Streilein J.W., and Niederkorn J.Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 153 (1981) 1058-1067
51. Faunce D.E., and Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 169 (2002) 31-38
52. D'Orazio T.J., Mayhew E., and Niederkorn J.Y. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol 166 (2001) 26-32
53. Niederkorn J.Y., Chiang E.Y., Ungchusri T., et al. Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 68 (1999) 1790-1799
54. Ikarashi Y., Mikami R., Bendelac A., et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J Exp Med 194 (2001) 1179-1186
55. Maeda M., Lohwasser S., Yamamura T., et al. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J Immunol 167 (2001) 4180-4186
56. Held W., Cado D., and Raulet D.H. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med 184 (1996) 2037-2041
57. Skold M., and Cardell S. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells. Eur J Immunol 30 (2000) 2488-2496
58. Ortaldo J.R., Winkler-Pickett R., Mason A.T., et al. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J Immunol 160 (1998) 1158-1165
59. Skelsey M.E., Mellon J., and Niederkorn J.Y. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 166 (2001) 4327-4333
60. Xu Y., and Kapp J.A. Gammadelta T cells are critical for the induction of anterior chamber-associated immune deviation. Immunology 104 (2001) 142-148
61. Cai J.L., and Tucker P.W. Gamma-delta T cells: immunoregulatory functions and immunoprotection. Chem Immunol 79 (2001) 99-138
62. Holtmeier W., and Kabelitz D. Gamma-delta T cells link innate and adaptive immune responses. Chem Immunol Allergy 86 (2005) 151-183
63. Brandes M., Willimann K., and Moser B. Professional antigen-presentation function by human gamma-delta T cells. Science 309 (2005) 264-268
64. Li X., Taylor S., Zegarelli B., et al. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. J Neuroimmunol 153 (2004) 40-49
65. Vega J., Keino H., and Streilein J.W. Immune privilege in the anterior chamber of the eye is disrupted by removal of the superior cervical ganglion (April 24, 2004), American Uveitis Society Meeting, Fort Lauderdale
66. Bellinger D.L., Lorton D., Romano T.D., et al. Neuropeptide innervation of lymphoid organs. Ann N Y Acad Sci 594 (1990) 17-33
67. Madden K.S., Felten S.Y., Felten D.L., et al. Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behav Immun 3 (1989) 72-89
68. Rice P.A., Boehm G.W., Moynihan J.A., et al. Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J Neuroimmunol 114 (2001) 19-27
69. Rook G.A., Lightman S.L., and Heijnen C.J. Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends Immunol 23 (2002) 18-22
70. Streilein J.W., Bradley D., Sano Y., et al. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci 37 (1996) 413-424
71. Sonoda Y., and Streilein J.W. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 150 (1993) 1727-1734
72. She S.C., Steahly L.P., and Moticka E.J. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci 31 (1990) 1950-1956
73. Niederkorn J.Y., and Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci 37 (1996) 2700-2707
74. Geiger K., and Sarvetnick N. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J Immunol 153 (1994) 5239-5246
75. Ohta K., Wiggert B., Taylor A.W., et al. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci 40 (1999) 2010-2018
76. Mo J.S., and Streilein J.W. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur J Immunol 31 (2001) 3806-3815
77. Mo J.S., and Streilein J.W. Analysis of immune privilege in eyes with Mycobacteria tuberculosa adjuvant-induced uveitis. Ocul Immunol Inflamm 13 (2005) 139-147
78. John S.W., Smith R.S., Savinova O.V., et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39 (1998) 951-962
79. Mo J.S., Wang W., and Kaplan H.J. Impact of inflammation on ocular immune privilege. Chem Immunol Allergy 92 (2007) 155-165
80. Adamek-Kotowicz E., and Lutjen-Drecoll E. Development of F4/80 positive cells and CGRP nerve terminals in the mouse uvea (abstract). Invest Ophthalmol Vis Sci 44 (2003) 744
81. Kitazawa T., and Streilein J.W. Hapten-specific tolerance promoted by calcitonin gene-related peptide. J Invest Dermatol 115 (2000) 942-948
82. Levite M. Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann N Y Acad Sci 917 (2000) 307-321
83. Streilein J.W., Alard P., and Niizeki H. Neural influences on induction of contact hypersensitivity. Ann N Y Acad Sci 885 (1999) 196-208
84. Wenkel H., Streilein J.W., and Young M.J. Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier. J Immunol 164 (2000) 5125-5131
85. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5 (2004) 266-271
86. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2 (2002) 656-663
87. Robertson S.A., Ingman W.V., O'Leary S., et al. Transforming growth factor beta-a mediator of immune deviation in seminal plasma. J Reprod Immunol 57 (2002) 109-128
88. Fijak M., and Meinhardt A. The testis in immune privilege. Immunol Rev 213 (2006) 66-81
89. Terabe M., Matsui S., Noben-Trauth N., et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1 (2000) 515-520
90. Kezuka T. Immune deviation and ocular infections with varicella zoster virus. Ocul Immunol Inflamm 12 (2004) 17-24
91. Rochat C., Polla B.S., and Herbort C.P. Immunological profiles in patients with acute retinal necrosis. Graefes Arch Clin Exp Ophthalmol 234 (1996) 547-552
92. Maizels R.M., Balic A., Gomez-Escobar N., et al. Helminth parasites-masters of regulation. Immunol Rev 201 (2004) 89-116
93. Goodridge H.S., Wilson E.H., Harnett W., et al. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol 167 (2001) 940-945
94. Hara Y., Caspi R.R., Wiggert B., et al. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J Immunol 149 (1992) 1531-1538
95. Okamoto S., Kosiewicz M.M., Caspi R.R., et al. ACAID as a potential therapy for established experimental autoimmune uveitis. In: Nussenblatt R.B., Whitcup S.M., Caspi R.R., et al. (Eds). Advances in ocular immunology (1994), Elsevier, Amsterdam 195-198
96. Faunce D.E., Terajewicz A., and Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol 172 (2004) 1991-1995
97. Zhang-Hoover J., and Stein-Streilein J. Tolerogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis. J Immunol 172 (2004) 178-185
98. Cousins S.W., McCabe M.M., Danielpour D., et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 32 (1991) 2201-2211
99. Kezuka T., and Streilein J.W. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 41 (2000) 1803-1811
100. Wilbanks G.A., Mammolenti M., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 22 (1992) 165-173
101. Wilbanks G.A., and Streilein J.W. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol 22 (1992) 1031-1036
102. Kuchroo V.K., Minami M., Diamond B., et al. Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression. J Immunol 141 (1988) 10-16
103. Masli S., Turpie B., Hecker K.H., et al. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol 168 (2002) 2264-2273
104. Rutella S., and Lemoli R.M. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett 94 (2004) 11-26